guest ::
| Home > Publications database > Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Patterns of Response and Survival According to the Presence of Hepatic and Extrahepatic Metastasis > print |
| Home > Publications database > Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Patterns of Response and Survival According to the Presence of Hepatic and Extrahepatic Metastasis > print |
| 001 | 169877 | ||
| 005 | 20240229133659.0 | ||
| 024 | 7 | _ | |a 10.3390/cancers13133359 |2 doi |
| 024 | 7 | _ | |a altmetric:110057642 |2 altmetric |
| 024 | 7 | _ | |a pmid:34283061 |2 pmid |
| 037 | _ | _ | |a DKFZ-2021-01611 |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Koch, Elias |b 0 |
| 245 | _ | _ | |a Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Patterns of Response and Survival According to the Presence of Hepatic and Extrahepatic Metastasis |
| 260 | _ | _ | |a Basel |c 2021 |b MDPI |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1626792001_22777 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 536 | _ | _ | |a 311 - Zellbiologie und Tumorbiologie (POF4-311) |0 G:(DE-HGF)POF4-311 |c POF4-311 |x 0 |f POF IV |
| 588 | _ | _ | |a Dataset connected to CrossRef, Journals: inrepo01.inet.dkfz-heidelberg.de |
| 700 | 1 | _ | |a Petzold, Anne |b 1 |
| 700 | 1 | _ | |a Wessely, Anja |0 0000-0003-1940-5115 |b 2 |
| 700 | 1 | _ | |a Dippel, Edgar |b 3 |
| 700 | 1 | _ | |a Gesierich, Anja |b 4 |
| 700 | 1 | _ | |a Gutzmer, Ralf |0 0000-0001-7921-2820 |b 5 |
| 700 | 1 | _ | |a Hassel, Jessica |b 6 |
| 700 | 1 | _ | |a Haferkamp, Sebastian |b 7 |
| 700 | 1 | _ | |a Hohberger, Bettina |b 8 |
| 700 | 1 | _ | |a Kähler, Katharina |b 9 |
| 700 | 1 | _ | |a Knorr, Harald |b 10 |
| 700 | 1 | _ | |a Kreuzberg, Nicole |b 11 |
| 700 | 1 | _ | |a Leiter, Ulrike |b 12 |
| 700 | 1 | _ | |a Loquai, Carmen |b 13 |
| 700 | 1 | _ | |a Meier, Friedegund |b 14 |
| 700 | 1 | _ | |a Meissner, Markus |0 0000-0002-5630-587X |b 15 |
| 700 | 1 | _ | |a Mohr, Peter |b 16 |
| 700 | 1 | _ | |a Pföhler, Claudia |0 0000-0003-0384-114X |b 17 |
| 700 | 1 | _ | |a Rahimi, Farnaz |b 18 |
| 700 | 1 | _ | |a Schadendorf, Dirk |b 19 |
| 700 | 1 | _ | |a Schell, Beatrice |b 20 |
| 700 | 1 | _ | |a Schlaak, Max |b 21 |
| 700 | 1 | _ | |a Terheyden, Patrick |b 22 |
| 700 | 1 | _ | |a Thoms, Kai-Martin |b 23 |
| 700 | 1 | _ | |a Schuler-Thurner, Beatrice |0 0000-0001-8653-5425 |b 24 |
| 700 | 1 | _ | |a Ugurel, Selma |0 0000-0002-9384-6704 |b 25 |
| 700 | 1 | _ | |a Ulrich, Jens |b 26 |
| 700 | 1 | _ | |a Utikal, Jochen |0 P:(DE-He78)a229f7724466e7efadf4a1ace1ff8af3 |b 27 |u dkfz |
| 700 | 1 | _ | |a Weichenthal, Michael |b 28 |
| 700 | 1 | _ | |a Ziller, Fabian |0 0000-0002-2519-1312 |b 29 |
| 700 | 1 | _ | |a Berking, Carola |b 30 |
| 700 | 1 | _ | |a Heppt, Markus |0 0000-0003-4603-1825 |b 31 |
| 773 | _ | _ | |a 10.3390/cancers13133359 |g Vol. 13, no. 13, p. 3359 - |0 PERI:(DE-600)2527080-1 |n 13 |p 3359 |t Cancers |v 13 |y 2021 |x 2072-6694 |
| 909 | C | O | |o oai:inrepo02.dkfz.de:169877 |p VDB |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 27 |6 P:(DE-He78)a229f7724466e7efadf4a1ace1ff8af3 |
| 913 | 0 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-311 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-300 |4 G:(DE-HGF)POF |v Signalling pathways, cell and tumor biology |x 0 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-311 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Zellbiologie und Tumorbiologie |x 0 |
| 914 | 1 | _ | |y 2021 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b CANCERS : 2019 |d 2021-05-04 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2021-05-04 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2021-05-04 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0320 |2 StatID |b PubMed Central |d 2021-05-04 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |d 2021-05-04 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |d 2021-05-04 |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b DOAJ : Blind peer review |d 2021-05-04 |
| 915 | _ | _ | |a Creative Commons Attribution CC BY (No Version) |0 LIC:(DE-HGF)CCBYNV |2 V:(DE-HGF) |b DOAJ |d 2021-05-04 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2021-05-04 |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2021-05-04 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2021-05-04 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2021-05-04 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2021-05-04 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2021-05-04 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2021-05-04 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2021-05-04 |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b CANCERS : 2019 |d 2021-05-04 |
| 915 | _ | _ | |a Article Processing Charges |0 StatID:(DE-HGF)0561 |2 StatID |d 2021-05-04 |
| 915 | _ | _ | |a Fees |0 StatID:(DE-HGF)0700 |2 StatID |d 2021-05-04 |
| 920 | 1 | _ | |0 I:(DE-He78)A370-20160331 |k A370 |l KKE Dermatoonkologie |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)A370-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|